Healthleap, a hospital AI platform that reads patient records to identify undiagnosed conditions, has raised $38 million across seed and Series A funding rounds.
The seed round of $8 million was co-led by Sequoia Capital and First Round Capital. Hummingbird Ventures led the $30 million Series A. The company did not disclose its valuation.
Founded in South Africa in 2022 by siblings Jemima and Josiah Meyer, Healthleap initially built a clinical nutrition tool for dietitians before pivoting to a broader platform. The startup now aims to flag hospital patients suffering from conditions like malnutrition and delirium that often go undetected early.
The platform plugs into hospital electronic health record systems and uses language models to extract clinical information from written clinician notes. It looks for mentions such as poor appetite, recent weight loss, muscle loss, and difficulty swallowing. That textual analysis combines with structured data like lab results and vital signs to generate risk scores. The company emphasizes its software does not diagnose but highlights patients for additional clinical review.
Healthleap currently operates in more than 50 hospitals, including Penn Medicine, Cedars-Sinai, Intermountain, Houston Methodist, and Emory Healthcare. Revenue grew more than 10-fold over the past year, though specific figures were not disclosed. The startup has grown from three hospital partners to over 50 in that same period.
According to CEO Josiah Meyer, "Each night, we analyze every adult inpatient's record: lab results, vital signs, weights, medications, diet orders, diagnoses, clinicians' notes, and more." Each morning, risk scores are written into the care team's existing workflow via a dashboard.
Healthleap sells three-year contracts priced by hospital bed count and uses outcome-based pricing. Meyer stated every customer to date has realized at least 5x return on investment, with some seeing over 20x annual ROI. At the Hospital of the University of Pennsylvania, the malnutrition program generated $23.8 million in annualized financial impact, comprising $6.3 million in additional reimbursement and $17.5 million from shorter hospital stays.
The company plans to use the new funding for engineering, product, sales, and customer success. Meyer said Healthleap ultimately aims to identify more than 40 major health conditions and expand into outpatient and home care settings.